Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic
Slate Medicines’ antibody drug is designed to block PACAP, a protein associated with migraines. The Phase 1-ready asset was licensed from China-based DartsBio Pharmaceuticals.
2026 Star Ratings Shift: 4 Strategies for MA Plans
Further change in the Star Ratings program is inevitable, but one thing won’t change: plans that make targeted investments in improving the member experience and clinical outcomes, driven by data, are the most likely to succeed and achieve a higher overall rating.
How AI Is Transforming Detection of Congenital Heart Defects
In prenatal cardiology, that clarity can mean earlier diagnoses, safer deliveries, and better supported families who are prepared for what lies ahead.
DOJ, Ohio File Antitrust Suit Against OhioHealth Over Payer Contracts
The Department of Justice and the state of Ohio filed an antitrust lawsuit against OhioHealth this week, alleging the health system used “all-or-nothing” contracts that force insurers to include all of its hospitals and physicians. The case highlights federal and state scrutiny of hospital consolidation and restrictive contracting practices — with potential implications for payers, patients and healthcare markets across the country.